Your browser doesn't support javascript.
[A case of polyneuropathy after COVID-19 vaccine].
Iseki, Mari; Nakayama, Hiroki; Watanabe, Mutsufusa; Uchibori, Ayumi; Chiba, Atsuro; Mizutani, Saneyuki.
  • Iseki M; Department of Neurology, Tokyo Metropolitan Bokutoh Hospital.
  • Nakayama H; Department of Neurology, Tokyo Metropolitan Bokutoh Hospital.
  • Watanabe M; Department of Neurology, Tokyo Metropolitan Bokutoh Hospital.
  • Uchibori A; Department of Neurology, Kyorin University Hospital.
  • Chiba A; Department of Neurology, Kyorin University Hospital.
  • Mizutani S; Department of Neurology, Tokyo Metropolitan Bokutoh Hospital.
Rinsho Shinkeigaku ; 62(7): 558-562, 2022 Jul 29.
Article in Japanese | MEDLINE | ID: covidwho-1912020
ABSTRACT
A 43-year-old-woman developed paresthesia, weakness of limbs, dysphagia and deep sensory impairment 12 days after vaccination of Pfizer COVID-19 vaccine. Her deep tendon reflexes were absent and cerebrospinal fluid showed normal cell counts and protein level. Anti-ganglioside antibodies were negative, and F wave frequency was decreased in nerve conduction studies. We diagnosed her as immune mediated polyneuropathy caused by COVID-19 vaccine, and plasma exchange improved her symptoms. Compared with Guillain-Barré syndrome and polyneuropathy following COVID-19 infection and COVID-19 vaccination, deep sensory impairment was the most characteristic of this case. We supposed that non-antigen specific mechanism played an important role in the pathogenesis of this case.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Vaccines / COVID-19 Type of study: Case report / Diagnostic study / Observational study Topics: Vaccines Limits: Adult / Female / Humans Language: Japanese Journal: Rinsho Shinkeigaku Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Vaccines / COVID-19 Type of study: Case report / Diagnostic study / Observational study Topics: Vaccines Limits: Adult / Female / Humans Language: Japanese Journal: Rinsho Shinkeigaku Year: 2022 Document Type: Article